Home LiteratureArticle Details
PMID: 9614508 Published · ppublish English Journal Article

Preserved Frank-Starling mechanism in human end stage heart failure.

Cardiovascular research ·Vol. 37 ·No. 2 ·1998-02-00 ·Pages 541-8

Weil J, Eschenhagen T, Hirt S, Magnussen O, Mittmann C, Remmers U, Scholz H

Abstract

The goal of the present study was to examine the ability of failing myocardium to respond to enhanced preload with an increase in force development. The effect of various preload conditions (2.5-15 mN) on force development was studied in right ventricular trabeculae carneae from explanted human failing hearts with ischemic cardiomyopathy (ICM, n = 5, 42 preparations) or idiopathic dilated cardiomyopathy (DCM, n = 9, 77 preparations). To determine the severity of cardiac impairment we measured the positive inotropic effect of beta-adrenoceptor stimulation and calcium (ISO/Ca2+ ratio) and the expression of atrial natriuretic peptide (ANP) mRNA in all hearts. (1) Force of contraction increased with stepwise augmentation of preload (length at 2.5 mN preload to length of maximal force development) from 3.7 +/- 0.5 (ICM) and 2.7 +/- 0.4 (DCM) to 8.3 +/- 0.9 and 6.5 +/- 0.8 mN/mm2, respectively (p < 0.05). (2) The ISO/Ca2+ ratio was 0.40 +/- 0.04 (ICM) and 0.35 +/- 0.03 (DCM), respectively. (3) ANP mRNA was expressed in all preparations, albeit at greatly varying levels (ICM 22.5 +/- 6.1 and DCM 18.7 +/- 4.7 normalized arbitrary units). (4) Contraction experiments performed in left ventricular tissue (n = 3, 32 preparations) essentially confirmed the results. The Frank-Starling mechanism is preserved in terminally failing human hearts irrespective of the underlying etiology. We found no relation between the severity of cardiac impairment as assessed by either ANP expression or the ISO/Ca2+ ratio and the ability of failing human myocardium to respond to enhanced preload with an increase in force development.

MeSH Terms
Adrenergic beta-Agonists/pharmacology Atrial Natriuretic Factor/genetics Autoradiography Blotting, Northern Calcium/pharmacology Female GTP-Binding Protein alpha Subunits, Gs/genetics Gene Expression Heart Failure/metabolism,physiopathology Heart Ventricles Humans In Vitro Techniques Isoproterenol/pharmacology Male Middle Aged Myocardial Contraction/drug effects Myocardium/metabolism RNA, Messenger/analysis Stimulation, Chemical
Chemicals
Adrenergic beta-Agonists RNA, Messenger Atrial Natriuretic Factor GTP-Binding Protein alpha Subunits, Gs Isoproterenol Calcium
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Weil J
Abteilung Allgemeine Pharmakologie, Universitäts Krankenhaus Eppendorf, Germany. [email protected]
Eschenhagen T
Hirt S
Magnussen O
Mittmann C
Remmers U
Scholz H
Article Info
Journal
Cardiovascular research
Abbr.
Cardiovasc Res
ISSN
0008-6363
Published
1998-02-00
Pages
541-8
Language
English
Region
England
NLM ID
0077427
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]